Hendrick Andrew M, Kahook Malik Y
Rocky Mountain Lions Eye Institute, University of Colorado Denver, 1675 North Ursula Street, Mail Stop F731, Aurora, CO 80045, USA.
Expert Rev Med Devices. 2008 Nov;5(6):673-7. doi: 10.1586/17434440.5.6.673.
Glaucoma is a leading cause of worldwide blindness. Treatment of this chronic disease, centered on lowering intraocular pressure (IOP), may require surgical intervention when medical and/or laser therapy fail to control IOP. Traditional glaucoma surgery, such as trabeculectomy, has been performed for decades and has a proven track record of success. Unfortunately, many complications such as hypotony and slow visual recovery are known to occur and can lead to significant patient morbidity. New devices are being developed to allow surgeons increased control with more predictable postoperative results. One such device, the Ex-PRESS mini glaucoma shunt, has undergone changes in design and method of insertion making it more appealing for use in patients requiring IOP-lowering surgery. We summarize pertinent literature and expand on the future role of this device in glaucoma surgery.
青光眼是全球失明的主要原因。这种慢性病的治疗以降低眼压(IOP)为核心,当药物和/或激光治疗无法控制眼压时,可能需要手术干预。传统的青光眼手术,如小梁切除术,已经开展了数十年,并且有成功的记录。不幸的是,已知会发生许多并发症,如低眼压和视力恢复缓慢,并且可能导致患者出现严重的发病情况。正在研发新设备,以使外科医生能够更好地控制手术,并获得更可预测的术后结果。一种这样的设备,即Ex-PRESS微型青光眼分流器,在设计和插入方法上已经有所改进,使其在需要降低眼压手术的患者中更具吸引力。我们总结了相关文献,并阐述了该设备在青光眼手术中的未来作用。